ENTITY

Rigel Pharmaceuticals (RIGL US)

2
Analysis
Health CareUnited States
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The Company's research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms.
more
Company Event04 Mar 2026 05:00 • Upcoming
Add To Calendar
Company Event03 Dec 2025 21:30 • Latest
Company Event18 Nov 2025 18:00
Company Event05 Nov 2025 05:30
Company Event06 Aug 2025 04:30
x